Peking University Fifth School of Clinical Medicine, Beijing, People's Republic of China.
Cardiology Department, Beijing Hospital, National Center of Gerontology, Beijing, People's Republic of China.
BMC Cardiovasc Disord. 2021 Aug 18;21(1):399. doi: 10.1186/s12872-021-02208-x.
To evaluate the safety and efficacy of excimer laser coronary atherectomy (ELCA) in patients with in-stent restenosis chronic total occlusions (ISR CTOs).
ISR CTOs are a challenge in percutaneous coronary intervention (PCI). Although they can be treated by ELCA, limited data are available on the effects of ELCA treatment in these patients.
Fifty-nine consecutive patients underwent PCI for ISR CTOs at Beijing Hospital between December 2017 and September 2020. According to whether or not ELCA was performed, they were divided into two groups. Quantitative coronary angiography (QCA) analyses were performed routinely, including measurement of the minimal lumen diameter and calculation of the percentage diameter stenosis. The procedural success rate, the frequency of peri-procedural complications, and the incidence rates of major adverse cardiac events (MACEs) over nine months were assessed. The primary endpoint in the study was the percentage diameter stenosis.
Procedure success was achieved in most patients in both groups (75.9%). Patients in the ELCA group exhibited a lower percentage diameter stenosis (24.5 ± 9.09 vs. 35.1 ± 18.6, p = 0.048) and a larger minimal lumen diameter (2.36 ± 0.29 mm vs. 1.78 ± 0.64 mm, p < 0.001) than those in the control group and the 9-month incidence rates of MACEs did not differ (9.5% vs 15.8%, p = 0.699).
This study demonstrated that ELCA may be a safe and effective technique in the treatment of ISR CTOs, and the use of ELCA can achieve good immediate angiographic results, as measured by QCA, without increasing peri-procedural complications or the incidence rates of 9-month MACEs.
评估准分子激光冠状动脉斑块切除术(ELCA)治疗支架内再狭窄慢性完全闭塞病变(ISR CTO)患者的安全性和有效性。
ISR CTO 是经皮冠状动脉介入治疗(PCI)的挑战。虽然可以通过 ELCA 进行治疗,但关于这些患者接受 ELCA 治疗的效果的数据有限。
2017 年 12 月至 2020 年 9 月,北京医院对 59 例 ISR CTO 患者进行了 PCI。根据是否进行 ELCA 治疗,将患者分为两组。常规进行定量冠状动脉造影(QCA)分析,包括测量最小管腔直径和计算直径狭窄百分比。评估手术成功率、围手术期并发症发生率和 9 个月内主要不良心脏事件(MACE)发生率。研究的主要终点是直径狭窄百分比。
两组患者的手术成功率均较高(75.9%)。ELCA 组患者的直径狭窄百分比较低(24.5±9.09%比 35.1±18.6%,p=0.048),最小管腔直径较大(2.36±0.29mm 比 1.78±0.64mm,p<0.001),与对照组相比,9 个月时 MACE 发生率无差异(9.5%比 15.8%,p=0.699)。
本研究表明,ELCA 治疗 ISR CTO 可能是一种安全有效的技术,ELCA 的应用可通过 QCA 测量达到良好的即刻血管造影结果,而不会增加围手术期并发症或 9 个月时 MACE 的发生率。